NCT04312841
- Conditions
- B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +28 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,018 public trials
2,029 recruiting studies
Immunoproliferative Disorders trial results
NCT02828358
- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
NCT03058289
- Conditions
- Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +51 more
- Locations
-
- USC Norris Los Angeles, California, United States
- USC HOAG Newport Beach, California, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- UMASS Memorial Medical Center Worcester, Massachusetts, United States
NCT05131815
- Conditions
- Astrocytoma, Behavior, Blood Protein Disorders, +92 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT04872413
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IIT2020-20-SHIRAZIP-WALK: Nature Walks
NCT04896580
- Conditions
- Behavior, Breast Cancer, Breast Diseases, +35 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT05844956
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Beijing, Beijing Municipality, China
- Research Site Guangzhou, Guangdong, China
- Research Site Zhengzhou, Henan, China
NCT00788684
- Conditions
- CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
- Locations
-
- University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
- Stanford University School of Med /ID# 9782 Stanford, California, United States
- Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
- Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
NCT05925270
- Conditions
- Alcohol Drinking, Alcohol Use Disorder, Mild, Alcohol Use Disorder, Moderate, +17 more
- Locations
-
- Butha Buthe District Hospital Butha-Buthe, Lesotho
- Seboche Hospital Butha-Buthe, Lesotho
- St. Paul's Health Centre Butha-Buthe, Lesotho
Completed
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
NCT01957735
- Conditions
- Brain Diseases, Brain Neoplasms, Cancer, +19 more
- Locations
-
- Palo Alto Medical Foundation Sunnyvale, California, United States
- Weill Cornell Solid Tumor Oncology Practice New York, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States